Skip to main content
OpenTrials

Clinical trial condition

Post-Essential Thrombocythemia (ET) MF

Explore clinical trials studying Post-Essential Thrombocythemia (ET) MF. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Post-Essential Thrombocythemia (ET) MF trial results

Completed

Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF

NCT01392443

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Nanjing, Jiangsu, China
View all 26 locations
View Trial Details

Related conditions